Land: Ierland
Taal: Engels
Bron: HMA (Heads of Medicines Agencies)
chicken infectious anemia virus active principles 4.5 TCID50
Lohmann Animal Health & Co.
QI01AD04
Oral lyophilisate
Chicken anaemia vaccine
Chicken Young
2011-05-06
1 PACKAGE LEAFLET DIRECTIONS FOR USE AviPro THYMOVAC Lyophilisate for use in drinking water 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Lohmann Animal Health GmbH, Heinz-Lohmann-Str. 4, 27472 Cuxhaven, Germany 2. NAME OF THE VETERINARY MEDICINAL PRODUCT AviPro THYMOVAC Lyophilisate for use in drinking water. 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) 1 dose contains ACTIVE SUBSTANCE: Live Chicken Anaemia Virus (CAV), strain Cux-1: 10 4.5 - 10 5.5 TCID 50 * *TCID 50 = tissue culture-infectious dose 50 %: the virus titre required to cause infection in 50 % of the inoculated cell cultures Host system: embryonated SPF-hen´s eggs Appearance: red to brown lyophilized cake 4. INDICATION(S) For protection of the vaccinated breeder against excretion of the chicken anemia virus and transmission of the virus to eggs. For this active immunisation, onset of immunity: 4 weeks duration of immunity: 43 weeks demonstrated by challenge. For passive protection conferred to the progeny against clinical signs and lesions of chicken anemia. The protection of the progeny is guaranteed for up to 51 weeks after vaccination of the breeder, and chicks are protected at one day old (as demonstrated by challenge). ATC Vet code: QI01AD04. 5. CONTRAINDICATIONS Do not use in unhealthy birds. 6. ADVERSE REACTIONS None. If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. 7. TARGET SPECIES 2 Chickens (breeders from 8 weeks of age) 8. DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMIN Lees het volledige document
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AviPro THYMOVAC Lyopilisate for use in drinking water. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose contains: ACTIVE SUBSTANCE: Live Chicken Anaemia Virus (CAV), strain Cux-1: 10 4.5 - 10 5.5 TCID 50 * *TCID 50 = tissue culture-infectious dose 50 %: the virus titre required to cause infection in 50 % of the inoculated cell cultures Host system: embryonated SPF-hen´s eggs EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate for use in drinking water. Appearance: red to brown lyophilized cake 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (breeders from 8 weeks of age) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIE S For protection of the vaccinated breeder against excretion of the chicken anemia virus and transmission of the virus to eggs. For this active immunisation, onset of immunity: 4 weeks duration of immunity: 43 weeks demonstrated by challenge. For passive protection conferred to the progeny against clinical signs and lesions of chicken anemia. The protection of the progeny is guaranteed for up to 51 weeks after vaccination of the breeder, and chicks are protected at one day old (as demonstrated by challenge). 4.3 CONTRAINDICATIONS Do not use in unhealthy birds. 4.4 SPECIAL WARNINGS None. 4.5 SPECIAL PRECAUTIONS FOR USE 2 SPECIAL PRECAUTIONS FOR USE IN ANIMALS Vaccination should be performed from 8 weeks of age onwards, but no later than 6 weeks before the onset of lay in order to ensure that protective immunity has developed prior to the onset of lay. Lees het volledige document